About us

We work together with

Management

Antonia Gabriel

CEO/CSO

Katharina Birkmann

CMO

Daniel Widmer

COO

R&D Team

Fabia Canonica

Ph.D. in Molecular Biology and Biophysics

Project Manager – Vaccine Development

Fadi Jebbawi

Ph.D. in Immunology, Molecular and Cellular Biology

Project Manager – Biomarker

Stanislav Pantelyushin

Ph.D. in Immunology

Project Manager – Research & Preclinical Development

Victoria Fettelschoss

M.Sc. in Biochemistry, B.Sc. in Industrial Engineering and Management

Research Associate

Juwela Lam

M.Sc. ETH in Food Science and “Human Health, Nutrition and Environment”

Research Associate

Jefferson Brito de Souza

B.Sc. in Biological Science

Trainee

Clinical Team

Antonia Gabriel (Fettelschoss)

Dr. Sc. ETH Microbiology and Immunology

Lead clinical studies

[email protected]

Katharina Birkmann

Dr. med. vet., Dip. ECEIM

Clinical study manager

[email protected]

Sophie Hug

Dr. med. vet., Dip. ECEIM

Clinical study manager

[email protected]

Topicals Team

Daniel Widmer

Lead Topicals

Victoria Fettelschoss

Product Owner

Simon Gabriel

Purchase and Distribution

Sara Straub

Social Media

Advisors

Prof. Dr. Med. Thomas M. Kündig

Chair of Dermatology and Venereology at the Medical Faculty of the University of Zurich
Director of the Dermatological Clinic at the University Hospital Zurich

Prof. Dr. phil. nat. Christian Surber

Professor of Dermatopharmacology and Hospital Pharmacy
i.a. expert in drug delivery from topical formulations, topical delivery vehicle design, topical bioavailability / bioequivalence testing, topical pharmacotherapy of barrier function impairment (dry skin, atopic dermatitis, psoriasis) and solar damage (skin cancer)

Founder

Dr. Antonia Gabriel (Fettelschoss)

Inventor and founder of Evax AG
Studied human biology at the University of Zurich and graduated with a Master of Science degree in 2008. She then started directly with a doctorate in immunology at ETH Zurich and graduated in 2011
During her doctorate, she worked part-time at the Clinical Trials Center Zurich and completed internships at the Swiss Institute for Allergy and Asthma (SIAF) and the Swiss Tropical Institute (TPH)
Certificate of Advanced Studies in Clinical Trial Management
After completing her doctorate, she worked as a scientist at Vifor Pharma and Saiba GmbH.
In addition to her work at Evax, she works as a group leader at the University of Zurich / University Hospital Zurich in the field of immunology
She started riding at the age of 5 and got to know Icelandic horses at the age of 12 and remains loyal to them to this day. Her family has since owned Icelandic horses, all of which were / are imports from Iceland and were / are affected by sweet itch

Prof. Martin Bachmann

Co-inventor and co-founder of Evax AG
Founder of Saiba GmbH
Autor von mehr als 200 wissenschaftlicher Publikationen.
Over 20 years of experience in the field of immunology and more than 10 years of experience in the biotech industry
Leading scientist in the field of active immunotherapy for chronic diseases
Inventor of over 40 patents in the vaccine field
Professor at Oxford, visiting professor at the University of Zurich and Professor of Immunology at the University of Bern

Grants

EVAX hat Mittel aus Schweizer Stipendien erhalten, darunter die Stiftung Forschung für das Pferd und die Kommission für Technologie und Innovation.

Evax uses cookies to provide you with the best possible service. If you continue surfing on the site, you consent to the use of cookie usage .